ATE149175T1 - Lactam dipeptide mit hle inhibierende aktivität. - Google Patents

Lactam dipeptide mit hle inhibierende aktivität.

Info

Publication number
ATE149175T1
ATE149175T1 AT93910157T AT93910157T ATE149175T1 AT E149175 T1 ATE149175 T1 AT E149175T1 AT 93910157 T AT93910157 T AT 93910157T AT 93910157 T AT93910157 T AT 93910157T AT E149175 T1 ATE149175 T1 AT E149175T1
Authority
AT
Austria
Prior art keywords
heterocyclic compounds
hle
dipeptide
lactam
inhibiting activity
Prior art date
Application number
AT93910157T
Other languages
English (en)
Inventor
Peter Robert Berstein
Royston Martin Thomas
Peter Warner
Donald John Wolanin
Original Assignee
Zeneca Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB929208380A external-priority patent/GB9208380D0/en
Priority claimed from GB929208379A external-priority patent/GB9208379D0/en
Priority claimed from GB929214448A external-priority patent/GB9214448D0/en
Priority claimed from GB929217364A external-priority patent/GB9217364D0/en
Priority claimed from GB929217362A external-priority patent/GB9217362D0/en
Priority claimed from GB929217363A external-priority patent/GB9217363D0/en
Application filed by Zeneca Ltd filed Critical Zeneca Ltd
Application granted granted Critical
Publication of ATE149175T1 publication Critical patent/ATE149175T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Genetics & Genomics (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
AT93910157T 1992-04-16 1993-04-15 Lactam dipeptide mit hle inhibierende aktivität. ATE149175T1 (de)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
GB929208380A GB9208380D0 (en) 1992-04-16 1992-04-16 Heterocyclic compounds
GB929208379A GB9208379D0 (en) 1992-04-16 1992-04-16 Heterocyclic amines
GB929214448A GB9214448D0 (en) 1992-07-08 1992-07-08 Heterocyclic agents
GB929217364A GB9217364D0 (en) 1992-08-14 1992-08-14 Heterocyclic agents
GB929217362A GB9217362D0 (en) 1992-08-14 1992-08-14 Heterocyclic compounds
GB929217363A GB9217363D0 (en) 1992-08-14 1992-08-14 Heterocyclic amines

Publications (1)

Publication Number Publication Date
ATE149175T1 true ATE149175T1 (de) 1997-03-15

Family

ID=27547161

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93910157T ATE149175T1 (de) 1992-04-16 1993-04-15 Lactam dipeptide mit hle inhibierende aktivität.

Country Status (13)

Country Link
EP (1) EP0630382B1 (de)
JP (1) JPH07505873A (de)
AT (1) ATE149175T1 (de)
AU (1) AU4076993A (de)
CA (1) CA2132543A1 (de)
DE (1) DE69308291T2 (de)
FI (1) FI944802L (de)
GB (1) GB9307555D0 (de)
HU (1) HUT70430A (de)
IL (1) IL105424A0 (de)
MX (1) MX9302215A (de)
NO (1) NO943909L (de)
WO (1) WO1993021212A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5618792A (en) * 1994-11-21 1997-04-08 Cortech, Inc. Substituted heterocyclic compounds useful as inhibitors of (serine proteases) human neutrophil elastase
US5998379A (en) * 1994-11-21 1999-12-07 Cortech Inc. Serine protease inhibitors-proline analogs
US6001811A (en) * 1994-11-21 1999-12-14 Cortech Inc. Serine protease inhibitors--N-substituted derivatives
US6150334A (en) * 1994-11-21 2000-11-21 Cortech, Inc. Serine protease inhibitors-tripeptoid analogs
US6100238A (en) * 1994-11-21 2000-08-08 Cortech Inc. Indole and tetrahydroisoquinoline containing Alpha-keto oxadiazoles as serine protease inhibitors
US6159938A (en) * 1994-11-21 2000-12-12 Cortech, Inc. Serine protease inhibitors comprising α-keto heterocycles
US6015791A (en) * 1994-11-21 2000-01-18 Cortech Inc. Serine protease inhibitors-cycloheptane derivatives
US20020119985A1 (en) 1994-11-21 2002-08-29 Albert Gyorkos Serine protease inhibitors
US6001813A (en) * 1994-11-21 1999-12-14 Cortech Inc. Val-pro containing α-keto oxadiazoles as serine protease inhibitors
US6001814A (en) * 1994-11-21 1999-12-14 Cortech Inc. Serine protease inhibitors
US5948785A (en) * 1995-04-27 1999-09-07 The Green Cross Corporation Heterocyclic amide compounds and pharmaceutical use of the same
AU734615B2 (en) * 1996-12-06 2001-06-21 Cortech, Inc. Serine protease inhibitors
US6656910B2 (en) 1997-12-04 2003-12-02 Cortech, Inc. Serine protease inhibitors
KR20010078725A (ko) 1998-06-03 2001-08-21 존 더블류. 갈루치 2세 세린 프로테아제 저해제로서의 펩토이드 및 비펩토이드를함유하는 알파-케토 옥사디아졸
EP1842884A3 (de) 2001-07-30 2010-11-24 Sanko Chemical Industry Co., Ltd. Antistatische Zusammensetzung und Herstellungsverfahren dafür
IL163453A0 (en) 2004-08-10 2009-02-11 Yeda Res & Dev Enzyme inhibitor in leukemia
EP2424841A1 (de) * 2009-04-27 2012-03-07 Elan Pharmaceuticals Inc. Pyridinonantagonisten von alpha-4-integrinen
WO2021053058A1 (en) 2019-09-17 2021-03-25 Mereo Biopharma 4 Limited Alvelestat for use in the treatment of graft rejection, bronchiolitis obliterans syndrome and graft versus host disease
LT4106757T (lt) 2020-04-16 2023-11-10 Mereo Biopharma 4 Limited Neutrofilų elastazės inhibitoriaus alvelestato panaudojimas kvėpavimo sistemos ligų, nulemtų alfa-1 antitripsino nepakankamumo, gydymui
JP2024540952A (ja) 2021-10-20 2024-11-06 メレオ バイオファーマ ４ リミテッド 線維化の治療における使用のための好中球エラスターゼ阻害剤

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0369391A3 (de) * 1988-11-15 1991-09-25 Boehringer Ingelheim Pharmaceuticals Inc. N-substituierte Amide
GB9207145D0 (en) * 1991-04-18 1992-05-13 Ici Plc Heterocyclic amides

Also Published As

Publication number Publication date
HU9402968D0 (en) 1995-02-28
EP0630382A1 (de) 1994-12-28
FI944802A0 (fi) 1994-10-12
WO1993021212A1 (en) 1993-10-28
FI944802A7 (fi) 1994-10-12
EP0630382B1 (de) 1997-02-26
DE69308291D1 (de) 1997-04-03
NO943909D0 (no) 1994-10-14
JPH07505873A (ja) 1995-06-29
HUT70430A (en) 1995-10-30
DE69308291T2 (de) 1997-06-26
AU4076993A (en) 1993-11-18
NO943909L (no) 1994-10-14
GB9307555D0 (en) 1993-06-02
IL105424A0 (en) 1993-08-18
MX9302215A (es) 1993-10-01
FI944802L (fi) 1994-10-12
CA2132543A1 (en) 1993-10-28

Similar Documents

Publication Publication Date Title
NO943910D0 (no) Laktam-peptider med HLE-hemmende virkning
NO923197D0 (no) Substituerte heterocykliske forbindelser
TW262475B (en) Heterocyclic amides, intermediates and process for their preparation and pharmaceutical compositions containing them
DE69314169D1 (de) Peptide mit eine alphaaminoboronaire gruppe and ihre verwendung als elastasehemmer
DE69308291D1 (de) Lactam Dipeptide mit HLE inhibierende Aktivität.
FI946202A0 (fi) Fluoria sisältäviä dipeptidejä inhibiittoreina ihmisen lenkosyyttielastaasi-inhibiittoreita vastaan
FI945696A0 (fi) Laktaamidipeptidejä, joilla on HLE:a inhiboiva aktiivisuus
ATE105302T1 (de) Fluoramid-derivate mit hemmender aktivitaet gegen menschliche leukozytenelastase.
ES2055866T3 (es) Derivados trifluorcetopeptidos utiles como inhibidores de elastasa de leucocitos humanos.
NO944659L (no) Laktam-dipeptider med HLE-inhiberende aktivitet